Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Me too, I was actually thinking the same thing the other day. Thoughts?
Dark pool purchase. I am under the impression that the 600K at the close was preemptive Russell re-balancing.
I am interested in what you are describing but I do not follow. May I ask you to describe in more detail?
I agree in that I would not make to much of it, just thought it was interesting that whomever was buying had to pay up 3% for a hundred lot....wide bid/ask spread / thinly traded AH.
It could also be shorts testing the waters to see what's available and at what price. They are certainly interested in what volume is available in case they need to exit stage loser, or manipulate further.
I know it's low volume but take a gander at the aftermarket price....that's a wide bid ask spread when the price can fluctuate 3%. Doesn't appear to be many sellers, if you have to bid up 3% to get someone to sell you a 100 lot. Again it's low volume.
I bought some shares in my 401K last Thursday, I bought some options yesterday, I have some firepower waiting to scoop up more shares in my 401K. Timing wise, I am waiting to purchase more shares, as I just added a significant portion to my holdings within the last week. I am working on my patience, because I want to buy more today.
Just so I am clear, are you inferring that I was attempting to spread FUD by asking my question? (A) I never mentioned that NWBO would buyout Cognate that was some other poster (B) I did argue that NWBO, upon FDA acceptance and increased scale, will be a stand alone entity, which is what I gather from pouring over their SEC filings. I believe that NWBO as a stand alone entity would be more valuable. That is my opinion. I own 1147 shares in my 401K account, and I now own 11 call options in my personal brokerage account, 6 of those options were purchased today, the other 5 were purchased at the beginning of the year went from out of the money to in the money. I have been involved with NWBO since December of 2013, I have gone through the ups and downs. Or follow me on twitter @83lease, and notice how @JacobPlieth made the following tweet to me on 2/20/15 "Wow - check out @83lease's lunatic Twitter feed. With that kind of following how can $NWBO possibly go wrong?" He is on my list of people who will receive a handwritten letter from me upon FDA approval, and AF will receive a crate of grapefruit juice from me as well. That is one of the reasons I am somewhat persistent with NWBO, because of all the actual FUD that is spread about NWBO.
To the board, I have been over numerous board, Twitter feeds, and YMB's and this board here is the best one I have encountered yet. The wealth of knowledge here is staggering (think of the number of hours of research spent going over all the details). To the board, thank you.
Good question, I would imagine that they would be required initially to setup the facility then NWBO would hire additional staff to maintain the facility moving forward. What would you assume would happen?
Vator read the quarterly and annual reports for insight into management.....for example (from the most recent annual report)
On August 19, 2014, we completed the acquisition of a facility and property in the U.K (“UK Facility”). The purchase price was £13 million ($20.8 million, excluding professional fees of $1.5 million associated with the purchase of the U.K Facility). The facility is an existing building of approximately 65,000 square feet. We plan to re-purpose the facility and have it built out as part of the expansion of manufacturing capacity, potentially doubling the building’s square footage. Such re-purposing requires approval of the applicable Planning Commission. If re-purposing is approved, then the specific design and engineering of the proposed build out will also have to be approved. In addition to the facility, the acquisition included about 25 acres of potentially developable land (as well as non-developable land). Any future development for business use will require removal of certain existing structures, permission from the Planning Commission for the intended purpose, and then permission from the Planning Commission for the specific designs and engineering.
Is there any mention of Cognate here? Answer.. none. NWBO plans to manufacture its own vaccine in the future, where commercially viable, and not contract with Cognate for everything. There is nothing negative about this, it is merely a plan for moving forward. I am interested in this plan and how this plan is moving along, that is why I brought it up for conversation/debate. Furthermore as some have pointed out, the manufacturing capacity is a requirement of the FDA for approval of the NDA, so I would argue that this is a material topic to discuss.
Just noticed this from another stock page on Yahoo, does anyone know if NWBO was at this event?
http://www.bizjournals.com/seattle/blog/health-care-inc/2015/06/seattle-biotechs-flock-to-philadelphia-to-talk.html?ana=yahoo
Seems as though this might be applicable to our current price movement. Just a guess
I find that an interesting criteria, how is the FDA to know how many will actually use the vaccine or any treatment for that matter, to identify an amount necessary prior to FDA approval? Seems circuitous. Are there any additional insights the board can provide to illuminate the subject manner?
Allow what to happen? I would like to discuss this in more detail as this will hopefully become the next topic of debate as the science and trials progress to approval. Then we will all be concerned about production. The facility on the UK is owned by NWBO not cognate. The asset is listed on NWBO balance sheet as construction in progress, for roughly $40 million. Cognate's facilities are not listed on NWBO's balance sheet. NWBO contract's with Cognate to produce the vaccine because NWBO does not have its own facilities, and cost wise, setting up facilities during the trial is not cost effective, or efficient use of time. Cognate's facilities already pass muster for FDA procedures, that requires time, and money to comply with. In my opinion building the facility in UK is a huge vote of confidence by Woodford as it's right in his backyard, his employees can check in from time to time to make sure that the process is moving forward in the absence of NWBO employees.
NWBO plans to be a stand alone entity, with manufacturing its own product. Upon further growth of NWBO they will reduce their need of Cognate's manufacturing for European patients. NWBO will probably maintain Cognate's facilities for US patients. One way that I see NWBO separating from Cognate in the US, is if the roll out is extremely successful and they can afford to purchase a new facility in the US, aside from that I would say NWBO will detach from Cognate for European production and maintain US production until a time when they can scale up and out on their own. Just my opinion, I think it makes sense, I welcome other explanations.
Looks like we need to update the 52 week high. Michonne I wanted to relay that the additional shares of NWBO that I purchased in honor of you last week are now up roughly 6-7%. I call it my Michonne Fund, it's weighted 100% in long shares of NWBO.
On the menu today we have a treat, it's a slow roasted short position. It's been in the oven for all of 2015. The meat (short argument) is just falling off the bone. It's such a delicacy that I only recommend eating 1-2% a day, so that you really get the flavor and taste.
Michonne I know your overlords won't let you buy any NWBO, so I'll buy some more NWBO for you. I'll just hold it in my account and keep all the proceeds for myself. I may remind you from time to time how "your" investment is doing in my account.
It was most likely a short, who decided to not roll their options forward, and closed some of their short position. Options are used for insurance for underlying positions, and there is a cost associated with the "insurance". As the options expire today, if a sizable position was covered by options that will expire at the end of the day, then the insurance coverage expires and creates new risk exposure.
And full disclosure from actors on a stage such as your self. I am a tax accountant, and I must list a disclosure on every email that I send when I hold myself out in public as an accountant that certain advice should not be relied upon. Similar to the disclosures by streetsweeper sludge report "disclosure streetsweeper is short". Here is my disclosure I am long shares and calls of NWBO. How about you? I know full well that any response you give has not and will not be verified....
I just freed some funds for purchasing more NWBO shares in my core account, and transferred some funds to my option account to purchase more on these dips. Probably options with at least 6 months until expiration.
Blackhawks just won the Stanley cup, up next NWBO is going to make a historic win. Shorts beware!
I agree with you about the pipeline. From RDHL's webiste there appears to be numerous trials in progress. My interest is building.
TO follow up my question, where is the estimate of 1-1.5 billion in sales in the US from, that is listed at the top of the board? The intro data seems dated on the top of the board, wondering if it's still an accurate estimate.
New to RDHL, I actually bought a "test" position on Friday after a brief review and a recommendation from Staccani (thank you Stac). Now I am interested and considering adding to my position, but before I do so, I will need to perform much more due diligence. I am writing to the board to gauge what is the perception of sales/number of patients/number of diagnosis per year pertaining to RHB-105 upon FDA approval? Thank you for your time. I find the market cap interesting in its value, and the efficacy over SOC interesting.
Noticed a new article by Wall Street journal. The article makes me think that even I could write articles for the Wall Street journal.
http://www.wsj.com/articles/biotech-gets-a-reality-check-1434307132
I was drawn to the part that mentions that people short be wary when the shorts retreat.... Or better yet we should attack them when they are weak. That is the short playbook against us, attack, attack, attack, until the target is dead.
I will carry the torch with afford and inquire, what is your intention on this board? Why are you here? Do you have a position in NWBO? What is your position in NWBO. For example, Disclaimer I am long NWBO and I stand to profit from future increases in the stock price.
It was meant as a slight/barb not an insult. Go Hawks!
That makes more sense, thank you.
There you are ready! I distinctly remember when I read one of your posts that sounded positive and thought to myself "how the tables have turned". I didn't say anything because I wanted to see how you would act and what you would say. It seems that you have reverted back to your natural state. Good for you. I do hope you are readyforabilliondollarmarketcap.....because it will be here with NWBO before you know it.
I wish I had the cash available to purchase my options outright upon expiration, but unfortunately I won't. I figure I can sell a couple to cover the cash requirement to purchase the remaining options shares outright. Time will tell.
Ready I still recall when you were not positive on NWBO I had a nickname for you it is/was "Readyforabilliondollarmarketcap" I hope you are because that's where we are heading quickly. My impression is that we will pause around the 1.2-1.5 billion market cap on this current run. If we have positive news, well then we are talking about a price that until now only existed in my dreams. I have some (now) deep in the money options. I spoke with my brokerage house today to discuss what my choices will be if at expiration they are in the money. Initially I was thinking of just closing the options, but my consideration now is that at expiration, I will sell just enough to buy the shares on expiration and hold the shares outright. I have NWBO holdings in two accounts, options in one, shares in the other. The account that currently holds shares will not be sold any time soon, for me they are committed to FDA approval.
Board what are your thoughts?
Thank you beach
This is my favorite line
Well Mich because you have never heard of one, then obviously it cannot exist. That is the premise of your argument from line one. I look forward to more data from NWBO, do you?
http://www.marketocracy.com/managers.php?type=all
I like their website. Apparently he is long 62,700 shares as part of his managed portfolio that has some pretty impressive gains (historically).
I think we are headed for 1.2-1.5 billion market cap very soon. At least I hope we are.
Yup. His tone has changed. Maybe because he claimed $NWBO was a scam and is now trading at 52 week highs. Or maybe because he claimed $MNKD would not get approval or progress and it recently had a huge positive move. Or maybe it's because he was so bullish on $CLDX and it has dropped significantly (15-20%) since ASCO. Or maybe it's because he is a political science major and has no certification in the scientific world, his supposed expertise. There are more but I can handle only so much of his BS.
Sloppy must have been busy talking with his bosses...."Boss don't jump". I wonder what kept him away from the screen and posting more of his "award winning" commentary. I will say that even though the title of the piece today claimed desperation of NWBO, it could not have been any more apparent to me that it was a desperate ploy by shorts and an indication that they are feeling an incredible amount of pressure from their losses. We are at the price where the shorts have an open wound that is bleeding profusely, requiring immediate attention.